Novel strategies for immuno-oncology breakthroughs with cell therapy

Cell therapy has evolved rapidly in the past several years with more than 250 clinical trials ongoing around the world. While more indications of cellular therapy with chimeric antigen receptor – engineered T cells (CAR-T) are approved for hematologic malignancies, new concepts and strategies of cel...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Hongtao, Pan, Chongxian, Song, Wenru, Liu, Delong, Li, Zihai, Zheng, Lei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8325826/
https://www.ncbi.nlm.nih.gov/pubmed/34332618
http://dx.doi.org/10.1186/s40364-021-00316-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8325826/
https://www.ncbi.nlm.nih.gov/pubmed/34332618
http://dx.doi.org/10.1186/s40364-021-00316-6

Ejemplares similares